Advertisement

Latest News

5 Nephrology Headlines You Missed in March 2026

10 minutes ago

Catch up on the guideline updates, trial news, and featured content from March 2026.

Diabetes Dialogue: 2026 AACE Guidelines for Type 2 Diabetes

1 hour ago

This episode discusses the recently released algorithm for T2D from the American Association of Clinical Endocrinology.

Q2 2026 Preview: 6 FDA Decisions to Watch

1 hour ago

Check out 6 FDA decisions to watch in Q2 2026, listed chronologically by expected decision date.

Tonlamarsen Lowers Angiotensinogen, Minimal Effects on Blood Pressure, With Luke Laffin, MD

1 hour ago

Laffin discusses results from the Kardinal study, which investigated a single dose of tonlamarsen followed by placebo against monthly tonlamarsen treatment in hypertension.

Discussing Future of Amlitelimab, OX40/OX40L Treatment, With Eingun James Song, MD

1 hour ago

In this AAD interview, Song highlights how he views the potential benefit of amlitelimab in light of discontinuing rocatinlimab.

Advertisement
Advertisement